Impact of Single Hemodialysis Treatment on immune Cell Subpopulations.
Chiara DonadeiAndrea AngelettiValeria PizzutiFulvia ZappuloDiletta ConteMaria Laura CappuccilliAnna Laura Croci ChiocchiniAnna ScrivoDelia ApuzzoMaria Addolorata MariggiòLorenzo GasperoniGabriele DonatiGaetano La MannaPublished in: Journal of clinical medicine (2023)
Hemodialysis (HD) is known to trigger a chronic inflammatory status, affecting the innate and acquired immune response. This study was aimed at a comparative analysis of immune cell subsets, proliferation, and apoptosis in subjects receiving chronic HD treatment with respect to a healthy control. Regardless of the dialysis filter used, we observed a reshaping of the acquired immune component both with respect to healthy patients and between the various sessions of dialysis treatment, with an impairment of CD3 cells, along with an increase in CD4 and CD8 cell populations producing pro-inflammatory factors such as IL-17 and IFN-gamma. The population of B cells, monocytes and NK cells were not impaired by the dialysis procedure. These results confirmed the high impact of the HD treatment on the patient's immune system, underlying the imbalance of T cell counterparts.
Keyphrases
- end stage renal disease
- chronic kidney disease
- immune response
- peritoneal dialysis
- nk cells
- prognostic factors
- inflammatory response
- cell cycle arrest
- signaling pathway
- oxidative stress
- case report
- peripheral blood
- toll like receptor
- bone marrow
- stem cells
- cell therapy
- newly diagnosed
- combination therapy
- replacement therapy
- pi k akt